Related Experiment Video
Updated: Jan 11, 2026

Collection, Isolation, and Flow Cytometric Analysis of Human Endocervical Samples
Published on: July 6, 2014
Female Sex is Protective Against MASLD With Clinically Significant Fibrosis in a Large Cross-sectional Cohort of
Kara Wegermann1, Ayako Suzuki2, Elisa Sarmiento3
1Division of Gastroenterology, Department of Medicine, Duke University Health System, Durham, NC, USA.
Background:
Men are at higher risk for metabolic dysfunction-associated steatotic liver disease (MASLD) with clinically significant fibrosis (CSF) than premenopausal women, but data are lacking in persons with HIV (PWH). The aim of this study was to discover prevalence and severity of MASLD in PWH by sex assigned at birth and menopausal status.
Methods:
We examined participants from the prospective, cross-sectional HIV NASH CRN who had suppressed HIV-1 RNA, self-reported sex assigned at birth and menopause status, and underwent transient elastography (TE). The primary outcome was MASLD (controlled attenuation parameter [CAP] ≥ 263 dB/m, ≥1 cardiometabolic risk factor, Alcohol Use Disorders Identification Test score <8) with CSF (MASLD-CSF, TE Liver Stiffness Measurement ≥ 8 kPa).
Results:
Nine hundred and sixty-four PWH were included: 709 men (73.5%) and 255 women (26.5%) with similar median ages (55.1 and 56.6 years, P-value = .08). The most common race was Black (52%). Women had lower prevalence of MASLD-CSF than men (5.5% vs 10.6%, P = .02). In a multivariable logistic regression model for MASLD-CSF, diabetes (OR 3.26 [95% confidence interval 2.01-5.30], P < .0001), hyperlipidemia (1.97 [1.14-3.39], P = .02), and waist circumference (WC) above sex-specific cutoff (women: 80 cm, men: 94 cm) (4.59 [2.12-9.93], P < .0001) were associated with higher odds of MASLD-CSF, while female sex was associated with lower odds (0.43 [0.23-0.81], P = .01). Variables and effect sizes associated with MASLD-CSF differed among sex/menopause subgroups.
Conclusions:
Female sex was protective against MASLD-CSF in PWH. Men with diabetes, hyperlipidemia, and high WC would be candidates for MASLD screening. Further studies of PWH with women, especially more young women, are needed.
Insights
Metabolic dysfunction-associated steatotic liver disease with significant fibrosis is less common in women living with HIV. Men with diabetes, hyperlipidemia, and larger waist circumference need MASLD screening.
Area of Science:
- Hepatology
- Infectious Disease (HIV/AIDS)
- Metabolic Syndrome
Background:
- Metabolic dysfunction-associated steatotic liver disease (MASLD) with clinically significant fibrosis (CSF) affects men more than women.
- Limited data exist on MASLD prevalence and severity in people with HIV (PWH).
- This study investigates MASLD-CSF in PWH stratified by sex and menopausal status.
Purpose of the Study:
- To determine the prevalence and severity of MASLD-CSF in people with HIV (PWH).
- To analyze differences in MASLD-CSF based on sex assigned at birth and menopausal status.
- To identify risk factors for MASLD-CSF in PWH.
Main Methods:
- Cross-sectional analysis of the HIV NASH CRN cohort.
- Inclusion criteria: suppressed HIV-1 RNA, self-reported sex and menopause status, transient elastography (TE).
- MASLD defined by controlled attenuation parameter (CAP ≥ 263 dB/m) and ≥1 cardiometabolic risk factor; CSF defined by TE Liver Stiffness Measurement (≥ 8 kPa).
Main Results:
- 964 PWH included: 709 men (73.5%) and 255 women (26.5%).
- Lower prevalence of MASLD-CSF in women (5.5%) compared to men (10.6%) (P = .02).
- Diabetes (OR 3.26), hyperlipidemia (OR 1.97), and high waist circumference (OR 4.59) increased MASLD-CSF odds; female sex was protective (OR 0.43).
Conclusions:
- Female sex is protective against MASLD-CSF in people with HIV.
- Men with diabetes, hyperlipidemia, and high waist circumference should be screened for MASLD.
- Further research is needed, particularly including more women, especially younger women, with HIV.
More Related Videos
10:12Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis
Published on: September 11, 2019
07:21Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment
Published on: June 23, 2019
Related Concept Videos
Sexually Transmitted Infections
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...